CONMED Price to Sales Ratio 2010-2023 | CNMD
Historical PS ratio values for CONMED (CNMD) over the last 10 years. The current P/S ratio for CONMED as of May 03, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| CONMED P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-05-03 |
71.76 |
|
1.82 |
| 2023-12-31 |
109.23 |
$39.44 |
2.77 |
| 2023-09-30 |
100.42 |
$37.42 |
2.68 |
| 2023-06-30 |
135.06 |
$36.66 |
3.68 |
| 2023-03-31 |
103.07 |
$35.97 |
2.87 |
| 2022-12-31 |
87.78 |
$33.40 |
2.63 |
| 2022-09-30 |
79.21 |
$33.55 |
2.36 |
| 2022-06-30 |
94.41 |
$32.45 |
2.91 |
| 2022-03-31 |
146.14 |
$31.00 |
4.71 |
| 2021-12-31 |
139.25 |
$31.52 |
4.42 |
| 2021-09-30 |
128.32 |
$31.60 |
4.06 |
| 2021-06-30 |
134.58 |
$31.94 |
4.21 |
| 2021-03-31 |
127.70 |
$29.61 |
4.31 |
| 2020-12-31 |
109.34 |
$29.40 |
3.72 |
| 2020-09-30 |
76.66 |
$29.79 |
2.57 |
| 2020-06-30 |
69.99 |
$29.55 |
2.37 |
| 2020-03-31 |
55.52 |
$32.15 |
1.73 |
| 2019-12-31 |
108.11 |
$32.46 |
3.33 |
| 2019-09-30 |
92.79 |
$31.88 |
2.91 |
| 2019-06-30 |
82.41 |
$30.99 |
2.66 |
| 2019-03-31 |
79.92 |
$30.25 |
2.64 |
| 2018-12-31 |
61.53 |
$29.80 |
2.06 |
| 2018-09-30 |
75.70 |
$29.30 |
2.58 |
| 2018-06-30 |
69.77 |
$29.10 |
2.40 |
| 2018-03-31 |
60.20 |
$28.41 |
2.12 |
| 2017-12-31 |
48.30 |
$28.64 |
1.69 |
| 2017-09-30 |
49.52 |
$27.35 |
1.81 |
| 2017-03-31 |
41.59 |
$27.53 |
1.51 |
| 2016-12-31 |
41.17 |
$27.37 |
1.50 |
| 2016-09-30 |
37.17 |
$26.93 |
1.38 |
| 2016-06-30 |
44.07 |
$26.38 |
1.67 |
| 2016-03-31 |
38.54 |
$25.96 |
1.48 |
| 2015-12-31 |
40.29 |
$25.82 |
1.56 |
| 2015-09-30 |
43.45 |
$25.98 |
1.67 |
| 2015-06-30 |
52.83 |
$26.24 |
2.01 |
| 2015-03-31 |
45.62 |
$26.52 |
1.72 |
| 2014-12-31 |
40.46 |
$27.13 |
1.49 |
| 2014-09-30 |
33.00 |
$27.34 |
1.21 |
| 2014-06-30 |
39.35 |
$27.46 |
1.43 |
| 2017-06-30 |
47.89 |
$27.58 |
1.74 |
| 2013-12-31 |
37.55 |
$27.14 |
1.38 |
| 2013-09-30 |
29.85 |
$26.92 |
1.11 |
| 2013-06-30 |
27.33 |
$27.01 |
1.01 |
| 2013-03-31 |
29.66 |
$26.45 |
1.12 |
| 2012-12-31 |
24.23 |
$26.50 |
0.91 |
| 2014-03-31 |
38.56 |
$26.30 |
1.47 |
| 2012-09-30 |
24.57 |
$26.25 |
0.94 |
| 2012-06-30 |
23.73 |
$25.97 |
0.91 |
| 2012-03-31 |
25.47 |
$25.70 |
0.99 |
| 2011-12-31 |
21.78 |
$25.27 |
0.86 |
| 2011-09-30 |
19.52 |
$25.16 |
0.78 |
| 2011-06-30 |
24.16 |
$25.14 |
0.96 |
| 2011-03-31 |
22.29 |
$24.98 |
0.89 |
| 2010-12-31 |
22.42 |
$24.58 |
0.91 |
| 2010-09-30 |
19.01 |
$24.76 |
0.77 |
| 2010-06-30 |
15.80 |
$24.73 |
0.64 |
| 2010-03-31 |
20.20 |
$24.21 |
0.83 |
| 2009-12-31 |
19.34 |
$23.86 |
0.81 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$2.160B |
$1.245B |
|
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
|
